新产业 (300832.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.2x

EV/EBITDA

18.5x

Market Cap

CNY 40.44B

MomentumView details →

1D Return

−0.77%

YTD Return

−8.44%

RSI (14)

56.3

ValuationView details →

P/E (Fwd)

20.2x

EV/EBITDA

18.5x

Market Cap

CNY 40.44B

RSI (14)

56.3

MomentumView details →

1D Return

−0.77%

YTD Return

−8.44%

ProfitabilityView details →

Gross Margin

70.60%

Net Margin

35.47%

EBITDA Margin

46.12%

ROE (TTM)

17.13%

ROA (TTM)

15.90%

Asset Turnover

0.45x

GrowthView details →

Revenue YoY

−1.25%

EPS YoY

−11.69%

FCF YoY

+101.73%

Revenue CAGR 3Y

+14.52%

EPS CAGR 3Y

+6.84%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.54

EPS Surprise

2.29%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.62

Avg Surprise (4Q)

2.29%

Rev Surprise

3.26%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

10.54x

Quick Ratio

8.64x

Div Yield

2.33%

Div Rate

CNY 1.20

Div Growth 1Y

−7.69%

Financials snapshotView financials →

Revenue (TTM)

4.58B

Net Income (TTM)

1.62B

Op. CF (TTM)

1.86B

Next earningsOct 22, 2026 →

Latest newsMore news →

Shenzhen New Industries Biomedical Engineering Co., Ltd. received a Class II Medical Device Registration Certificate from the Guangdong Provincial Drug Administration for its angiotensin-converting enzyme assay kit (FAPGG substrate method), valid from 2026-08-19 to 2031-08-18.12d ago

Similar companies

云南铜业000878.SZ 冰轮环境000811.SZ 多氟多002407.SZ 联特科技301205.SZ 联合动力301656.SZ 华润三九000999.SZ Find similar companies →

Latest newsMore news →

Shenzhen New Industries Biomedical Engineering Co., Ltd. received a Class II Medical Device Registration Certificate from the Guangdong Provincial Drug Administration for its angiotensin-converting enzyme assay kit (FAPGG substrate method), valid from 2026-08-19 to 2031-08-18.12d ago